Q2 2024 NeueHealth Inc Earnings Call Transcript
Key Points
- NeueHealth Inc (NEUE) secured up to $150 million in a new term loan facility with Hercules Capital, significantly strengthening its capital position.
- The company served over 477,000 consumers across the ACA Marketplace, Medicare, and Medicaid in Q2 2024, demonstrating its ability to manage diverse populations.
- NeueHealth Inc (NEUE) delivered enterprise adjusted EBITDA of $4 million in the second quarter.
- The NeueCare segment achieved segment-adjusted EBITDA of $13.5 million, showing positive momentum.
- The company has a robust pipeline for 2025 and beyond, with strategic growth opportunities surfacing organically from existing partnerships.
- NeueCare operating costs were higher than expected due to a long-lived asset impairment expense.
- The NeueSolutions segment reported an operating loss of $397,000 for the second quarter.
- The wind down of the ACA insurance business is ongoing, with $135 million in excess cash reserved for expected medical costs and other wind down expenses.
- The company had $60.7 million of restricted cash and investments, limiting its immediate liquidity.
- Despite strong performance, the company reaffirmed a relatively modest full-year adjusted EBITDA expectation of between $15 million and $25 million.
Good morning, all. Welcome to the NeueHealth Q2 2024 earnings call. My name is Carly, and I'll be your call coordinator today. I would like to hand over to your host, Emily Lombardi. Please begin.
Good morning, and welcome to NeueHealth's second-quarter 2024 earnings conference Call. As a reminder, this call is being recorded. Leading the call today are NeueHealth's President and CEO, Mike Mikan; and CFO, Jay Matushak.
Before we begin, we want to remind you that this call may contain forward-looking statements under US federal securities laws. These statements are subject to risks and uncertainties that could cause actual results to differ materially from historical experience or present expectations.
A description of some of the risks and uncertainties can be found in the reports that we file with the Securities and Exchange Commission, including the risk factors in our current and periodic reports we file with the SEC. Except as required by law
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
